LIONHEAD(SH:600539) Xin Lang Cai Jing·2025-10-24 12:38Core Viewpoint - Lion Technology Development Co., Ltd. (Lion Shares) has applied for an extension to respond to the inquiry letter from the Shanghai Stock Exchange regarding its major asset restructuring involving the acquisition of 97.4399% of Hangzhou Lipo Technology Co., Ltd. [1][2] Group 1 - Lion Shares received the inquiry letter on September 19, 2025, and is required to submit a written response within one month [1][2] - The company has engaged relevant intermediary institutions to address the issues raised in the inquiry letter but requires more time to complete the necessary work [2] - The core content of the transaction involves Lion Shares acquiring the majority stake in Hangzhou Lipo Technology through a combination of issuing shares and cash payments [2] Group 2 - The transaction is subject to approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission, with uncertainties regarding the approval timeline [2] - Lion Shares will fulfill its information disclosure obligations in a timely manner based on the progress of the transaction [2]